Bridgecreek Investment Management’s Merck MRK Stock Holding History

Bridgecreek Investment Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$4.4M	Sell	40,335 -7,600	-16%	-$789K	0.85%	38
2023 Q3	$4.93M	Sell	47,935 -1,060	-2%	-$114K	1.01%	30
2023 Q2	$5.65M	Sell	48,995 -375	-0.8%	-$42.6K	1.08%	25
2023 Q1	$5.25M	Sell	49,370 -1,100	-2%	-$119K	1.08%	32
2022 Q4	$5.6M	Sell	50,470 -6,250	-11%	-$639K	1.25%	28
2022 Q3	$4.88M	Sell	56,720 -550	-1%	-$49.1K	1.04%	32
2022 Q2	$5.22M	Buy	57,270 +13,205	+30%	+$1.17M	1.08%	31
2022 Q1	$3.62M	Buy	44,065 +40,790	+1,245%	+$3.22M	0.54%	56
2021 Q4	$251K	Sell	3,275 -575	-15%	-$45.8K	0.03%	108
2021 Q3	$289K	Hold	3,850	–	–	0.04%	100
2021 Q2	$299K	Sell	3,850 -185	-5%	-$13.8K	0.04%	93
2021 Q1	$297K	Hold	4,035	–	–	0.05%	86
2020 Q4	$315K	Hold	4,035	–	–	0.05%	83
2020 Q3	$319K	Hold	4,035	–	–	0.06%	78
2020 Q2	$298K	Hold	4,035	–	–	0.06%	74
2020 Q1	$296K	Hold	4,035	–	–	0.08%	67
2019 Q4	$350K	Hold	4,035	–	–	0.06%	95
2019 Q3	$324K	Hold	4,035	–	–	0.07%	93
2019 Q2	$323K	Hold	4,035	–	–	0.07%	88
2019 Q1	$320K	Hold	4,035	–	–	0.07%	89
2018 Q4	$294K	Hold	4,035	–	–	0.08%	81
2018 Q3	$273K	Sell	4,035 -393	-9%	-$25K	0.05%	99
2018 Q2	$256K	Sell	4,428 -26	-0.6%	-$1.47K	0.06%	101
2018 Q1	$231K	Buy	4,454 +393	+10%	+$21.2K	0.05%	110
2017 Q4	$218K	Hold	4,061	–	–	0.05%	107
2017 Q3	$248K	Hold	4,061	–	–	0.07%	90
2017 Q2	$248K	Hold	4,061	–	–	0.07%	93
2017 Q1	$246K	Hold	4,061	–	–	0.07%	93
2016 Q4	$228K	Buy	4,061 +26	+0.6%	+$1.52K	0.06%	96
2016 Q3	$240K	Hold	4,035	–	–	0.07%	92
2016 Q2	$222K	Hold	4,035	–	–	0.07%	86
2016 Q1	$204K	Hold	4,035	–	–	0.07%	84
2015 Q4	$203K	Sell	4,035 -435	-10%	-$21.9K	0.06%	85
2015 Q3	$211K	Hold	4,470	–	–	0.06%	88
2015 Q2	$243K	Hold	4,470	–	–	0.06%	99
2015 Q1	$245K	Hold	4,470	–	–	0.06%	103
2014 Q4	$242K	Buy	4,470 +54	+1%	+$3.01K	0.06%	98
2014 Q3	$250K	Hold	4,416	–	–	0.07%	96
2014 Q2	$244K	Hold	4,416	–	–	0.06%	96
2014 Q1	$239K	Hold	4,416	–	–	0.07%	98
2013 Q4	$211K	Buy	4,416 +381	+9%	+$17.4K	0.06%	100
2013 Q3	$183K	Hold	4,035	–	–	0.05%	109
2013 Q2	$179K	Buy	+4,035	New	+$180K	0.06%	101

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bridgecreek Investment Management's MRK Position: Q4 2023 in Review

Bridgecreek Investment Management reduced its Merck (MRK) stake by 16% in Q4 2023, selling an estimated $789K and leaving 40,335 shares worth $4.4M. The position accounts for 0.85% of the portfolio, ranked #38.

Bridgecreek Investment Management first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $5.65M in Q2 2023. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

Bridgecreek Investment Management held 40,335 shares of Merck worth $4.4M as of Q4 2023.
Bridgecreek Investment Management sold 7,600 Merck shares in Q4 2023, an estimated $789K.
Merck made up 0.85% of Bridgecreek Investment Management's portfolio in Q4 2023, its #38 holding.
Bridgecreek Investment Management first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
Bridgecreek Investment Management's Merck position peaked at $5.65M in Q2 2023.
3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Bridgecreek Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.